Market Overview

Dynex Technologies Announces Global Partnership with ZEUS Scientific


Agreement to provide Dynex instruments through ZEUS' sales channels

Dynex® Technologies announced today it has finalized a
supply agreement with ZEUS Scientific (Branchburg, NJ) enabling ZEUS to
sell Dynex instruments to the global clinical market. This new direct
partnership builds on the long standing relationship between both
companies with Dynex Technologies' industry proven DS2®, DSX®
and Agility® automated ELISA instrumentation and ZEUS
Scientific's broad range of ZEUS ELISA™ Test Systems which use
common reagents and universal protocols across a diverse autoimmune and
infectious disease menu.

With an instrument base of over 6,000 systems globally, Dynex has a
proven track record of quality, acceptance and success in automating
clinical laboratories. Designed with the automated laboratory in mind,
the ZEUS ELISA™ Test System menu (featuring over 50 U.S. FDA cleared
tests) optimizes workflow efficiency with simplified automation
programming including multi-batching of test systems on the same plate
leading to better throughput and faster integration into the laboratory.

"ZEUS and Dynex have long worked together in an unofficial capacity and
diagnostic laboratories around the world have chosen the combined
solution of ZEUS' best-in-class IVD Test Systems with Dynex's
best-in-class microplate processing systems. Now that we are directly
selling and supporting the ZEUS ELISA products to the United States
marketplace, in conjunction with the Dynex automation systems, ZEUS is
positioned to offer the most flexible and efficient microplate testing
options in the autoimmune and infectious disease markets. And providing
this complete solution to our global network of distributors provides
even greater reach to these best-in-class solutions in diagnostic
laboratories around the world," said Chris Howard, Chief Commercial
Officer of ZEUS Scientific.

This strategic partnership with ZEUS Scientific allows laboratory
customers a single point of contact, full solution for their automated
ELISA testing needs improving the installation, training and
implementation process. With multiple instrument offerings and a broad in
diagnostic test menu, customers can choose a "right-sized"
instrument and test menu solution that fits their needs.

"Partnering with ZEUS aligns with our initiatives to drive growth of our
core product line by leveraging ZEUS' strong ELISA menu and growing
customer base," remarked David Sholehvar, M.D., Chief Executive Officer,
of Dynex Technologies. "ZEUS has a strong reputation as a provider of
quality ELISA products for autoimmune and infectious disease testing and
we look forward to strengthening our relationship in our effort to
deliver best-in-class solutions to the market."

Dynex Technologies, booth 3441, and ZEUS Scientific, booth 4063, will
both be exhibiting at AACC in Chicago from July 31 through August 2,
2018. Stop by to discuss ways to improve your automated ELISA testing

About Dynex Technologies (
Dynex® is an original pioneer of and a market leader in
automated microplate technology. Our talented, multidisciplinary staff
of approximately 125 people worldwide include design and service
engineers, applications scientists, marketing, sales specialists, and
precision-manufacturing experts. We are dedicated to perpetual
innovation in product design and new applications frontiers to deliver
cutting-edge microplate processing systems that meet the rigorous
demands of the most challenging applications, which ultimately improve
health outcomes and enhance life. Contact us at (703) 631-7800 or

About ZEUS Scientific (
ZEUS Scientific is your first choice for high-performing,
easy-to-use clinical diagnostic solutions. Our products are designed and
manufactured to ensure optimal efficiency and accurate diagnosis to
facilitate better patient care. ZEUS Scientific is based in Branchburg,
New Jersey and complies with the international standard ISO 13485
(2003), Health Canada Medical Device Regulations (SOR/98-282, May 7
1998), the FDA Quality System Regulations (FDA Quality System
Regulation, 1996: 21 CFR § 820), and the IVD 98/79/EEC. Contact us at
(800) 526-3744 or

View Comments and Join the Discussion!